D. Popp

A 6-week Randomized, Double-blind, Placebo-controlled, Comparator Referenced, Multicenter Trial of Vabicaserin in Subjects With Acute Exacerbation of Schizophrenia

M. Detke, E. Giller, J. Kane, 2011 .

A 6-week randomized, double-blind, placebo-controlled, comparator referenced trial of vabicaserin in acute schizophrenia.

M. Detke, E. Giller, Janet B W Williams, 2014, Journal of psychiatric research.

The value of risk reduction in CNS drug development: use of expected net present value (eNPV) as a model

M. Detke, J. Kane, P. Gilbert, 2013 .